Viewing Study NCT04817618

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2026-03-14 @ 9:29 PM
Study NCT ID: NCT04817618
Status: RECRUITING
Last Update Posted: 2025-03-04
First Post: 2021-03-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None C3G View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LNP023 View
None iptacopan View
None C3G View
None UPCR View
None eGFR View
None proteinuria View
None Quality of life View